Regulatory reporting in the context of cancer involves the process of submitting clinical data, treatment outcomes, and adverse events related to cancer therapies to appropriate regulatory bodies. This ensures that treatments are safe, effective, and compliant with national and international standards. Regulatory bodies such as the FDA in the United States or the EMA in Europe play a critical role in overseeing these reports.
